Nabil Asaad, PhD

Collaborateur senior

Nabil Asaad, PhD

Nabil specialises in IP and regulatory advice for clients ranging from start-ups to global players, with a particular focus on the life sciences and other technology-rich sectors.

Nabil provides pragmatic, commercially-minded advice with a focus on intellectual property strategy and regulatory compliance. In addition to advice on the identification, protection, commercialisation and enforcement of IP rights, Nabil supports clients with commercial contracts, due diligence, and regulatory compliance.

Prior to training as a solicitor, Nabil worked in early phase pharmaceutical R&D for AstraZeneca and chaired the Physical Organic Chemistry Group of the Royal Society of Chemistry.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

Global pharma groups Eli Lilly and AbbVie withdraw from UK’s branded medicines voluntary scheme

18 janvier 2023
Briefing

par Nabil Asaad, PhD et Lauren Mounteney

Cliquer ici pour en savoir plus
computing
Interface - Quantum computing - the next really big thing

Using quantum computing in life sciences

Nabil Asaad looks at the potential for quantum computing to revolutionise life sciences.

14 mars 2022

par Nabil Asaad, PhD

2 de 4 Publications

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Advising IP Group on option exercise to accelerate development of first-in-class gene therapy for patients with cystic fibrosis

29 octobre 2021

par Colin McCall et Nabil Asaad, PhD

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Word on the street at the J.P. Morgan Healthcare Conference 2023

1 février 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus

Autres avocats qui pourraient vous intéresser